The gemfibrozil cost-benefit model :
analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population /
Syam Sarma.

Description

Main Author

Sarma, Syam.

Related Names

Rand Graduate School.

Language(s)

English

Published

Santa Monica, CA (1700 Main St., P.O. Box 2138, Santa Monica 90407-2138) : RAND, 1993.

Subjects

Medicaid > Medicaid / California.
Digoxin.
Coronary heart disease > Coronary heart disease / Prevention > Coronary heart disease / Prevention / Finland.
Coronary heart disease > Coronary heart disease / Treatment.
Medicaid > Medicaid / economics > Medicaid / economics / California > Medicaid / economics / California / statistics.
Coronary Disease > Coronary Disease / economics > Coronary Disease / economics / United States > Coronary Disease / economics / United States / statistics.
Hyperlipidemias > Hyperlipidemias / drug therapy.
Gemfibrozil > Gemfibrozil / therapeutic use.
Cost-Benefit Analysis > Cost-Benefit Analysis / economics > Cost-Benefit Analysis / economics / United States > Cost-Benefit Analysis / economics / United States / statistics.

Note

"RSGD-105."

Physical Description

ix, 139 p. : ill.

Locate a Print Version

Find in a library

Viewability